Rhiannon D'Agostin uses her scientific and legal experience to develop practical strategies to protect and leverage her clients’ intellectual property. Her practice is focused on intellectual property counseling, including patent portfolio strategy and management, and encompasses both offensive and defensive considerations. She assists clients in a wide range of technologies such as biologics, diagnostics, medical devices, pharmaceuticals, cellular agriculture and manufacturing processes and systems.
Before attending law school, she worked as a scientist for a large biologics company where she developed an invaluable understanding of the biotech industry. She now assists clients with intellectual property portfolio management, patent prosecution, proceedings before the USPTO, validity and infringement opinions, freedom to operate analysis, intellectual property due diligence, licensing and research agreements, Hatch-Waxman related issues and patent litigation.
Awards and recognitions
- Legal 500 US, Recommended Lawyer, Healthcare - life sciences, The Legal 500, 2025
- IAM Patent 1000, Law Business Research Ltd., 2024-2026
- Denver Super Lawyers Rising Stars, Intellectual Property, Thomson Reuters, 2018
Education
- JD, University of North Carolina at Chapel Hill School of Law, 2008
- MS, University of North Carolina at Chapel Hill, 2003
- BS, Truman State University, 2000
Admissions
- Colorado State Bar
- District of Columbia Bar
- US Patent and Trademark Attorney
- Virginia State Bar
Speaking engagements
- Presenter, “Intellectual Property Law and Biomedical Innovation,” University of Texas Southwestern Medical Center Biomedical Innovation Program, October 21, 2021
Membership and activities
- American Bar Association
- National Association of Women Lawyers
- Colorado Bar Association
- Denver Bar Association
- AUTM